Retraction: Measles-mumps-rubella vaccination timing and autism among young African American boys: A reanalysis of CDC data [Transl Neurodegener, 3, (2014), 16], 10.1186/2047-9158-3-16;Measles-mumps-rubella vaccination timing and autism among young african american boys: A reanalysis of CDC data

Translational Neurodegeneration

Volumn 3, Issue 1, 2014, Pages

  Hooker, Brian S ^a  

^a Simpson University   (United States)

Author keywords

Autism; Measles mumps rubella (MMR) vaccine

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ACTIVE IMMUNIZATION; AFRICAN AMERICAN; AGE; ARTICLE; AUTISM; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASLES; MUMPS; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; RUBELLA; SEX DIFFERENCE; TIME TO TREATMENT;

EID: 84905816851     PISSN: None     EISSN: 20479158     Source Type: Journal    
DOI: 10.1186/2047-9158-3-22     Document Type: Erratum

References (30)

1. Geier DA, Kern JK, Geier MR. A Comparison of the Autism Treatment Evaluation Checklist (ATEC) and the Childhood Autism Rating Scale (CARS) for the Quantitative Evaluation of Autism. J Ment Health Res Intellect Disabil 2013, 6:255-267.
2. Boyle CA, Boulet S, Schieve LA, Cohen RA, Blumberg SJ, Yeargin-Allsopp M, Visser S, Kogan MD. Trends in the prevalence of developmental disabilities in US children, 1997-2008. Pediatrics 2011, 127:1034-1042.
3. Developmental Disabilities Monitoring Network Surveillance Year Principal I Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010. Morb Mortal Wkly Rep Surveill Summ 2014, 63 Suppl 2:1-21. Developmental Disabilities Monitoring Network Surveillance Year Principal I.
4. Geier DA, Kern JK, Geier MR. A prospective cross-sectional cohort assessment of health, physical, and behavioral problems in autism spectrum disorders. Maedica 2012, 7:193-200.
5. Kern JK, Geier DA, Sykes LK, Geier MR. Evidence of neurodegeneration in autism spectrum disorder. Transl Neurodegeneration 2013, 2:17.
6. Davidovitch M, Glick L, Holtzman G, Tirosh E, Safir MP. Developmental regression in autism: maternal perception. J Autism Dev Disord 2000, 30:113-119.
7. Wakefield AJ, Montgomery SM. Autism, viral infection and measles-mumps-rubella vaccination. Isr Med Assoc J 1999, 1:183-187.
8. Geier DA, Geier MR. A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism. Med Sci Monit 2004, 10:PI33-39.
9. Geier DA, Geier MR. Pediatric MMR Vaccination Safety. Int Pediatr 2003, 18:108-113.
10. Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, Olsen J, Melbye M. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 2002, 347:1477-1482.
11. Uno Y, Uchiyama T, Kurosawa M, Aleksic B, Ozaki N. The combined measles, mumps, and rubella vaccines and the total number of vaccines are not associated with development of autism spectrum disorder: the first case-control study in Asia. Vaccine 2012, 30:4292-4298.
12. Mrozek-Budzyn D, Kieltyka A, Majewska R. Lack of association between measles-mumps-rubella vaccination and autism in children: a case-control study. Pediatr Infect Dis J 2010, 29:397-400.
13. Fombonne E, Zakarian R, Bennett A, Meng L, McLean-Heywood D. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations. Pediatrics 2006, 118:e139-150.
14. DeStefano F, Bhasin TK, Thompson WW, Yeargin-Allsopp M, Boyle C. Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects: a population-based study in metropolitan atlanta. Pediatrics 2004, 113:259-266.
15. Durkin MS, Maenner MJ, Meaney FJ, Levy SE, DiGuiseppi C, Nicholas JS, Kirby RS, Pinto-Martin JA, Schieve LA. Socioeconomic inequality in the prevalence of autism spectrum disorder: evidence from a U.S. cross-sectional study. PLoS One 2010, 5:e11551.
16. Ginde AA, Liu MC, Camargo CA. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009, 169:626-632.
17. Patrick RP, Ames BN. Vitamin D hormone regulates serotonin synthesis. Part 1: relevance for autism. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 2014, 28:2398-2413.
18. Zafeiriou DI, Ververi A, Vargiami E. The serotonergic system: its role in pathogenesis and early developmental treatment of autism. Curr Neuropharmacol 2009, 7:150-157.
19. Crockett MJ. The neurochemistry of fairness: clarifying the link between serotonin and prosocial behavior. Ann N Y Acad Sci 2009, 1167:76-86.
20. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004, 80:1678S-1688S.
21. Tsoukas CD, Provvedini DM, Manolagas SC. 1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone. Science 1984, 224:1438-1440.
22. Bhalla AK, Amento EP, Clemens TL, Holick MF, Krane SM. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 1983, 57:1308-1310.
23. Cantorna MT, Munsick C, Bemiss C, Mahon BD. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 2000, 130:2648-2652.
24. Hoffecker BM, Raffield LM, Kamen DL, Nowling TK. Systemic lupus erythematosus and vitamin D deficiency are associated with shorter telomere length among African Americans: a case-control study. PLoS One 2013, 8:e63725.
25. Ford JL, Stowe RP. Racial-ethnic differences in Epstein-Barr virus antibody titers among U.S. children and adolescents. Ann Epidemiol 2013, 23:275-280.
26. Fagundes CP, Glaser R, Hwang BS, Malarkey WB, Kiecolt-Glaser JK. Depressive symptoms enhance stress-induced inflammatory responses. Brain Behav Immun 2013, 31:172-176.
27. Gallagher CM, Goodman MS. Hepatitis B vaccination of male neonates and autism diagnosis, NHIS 1997-2002. J Toxic Environ Health A 2010, 73:1665-1677.
28. Singh GK, Kenney MK, Ghandour RM, Kogan MD, Lu MC. Mental Health Outcomes in US Children and Adolescents Born Prematurely or with Low Birthweight. Depression Res Treat 2013, 2013:570743.
29. Verstraeten T, Davis RL, DeStefano F, Lieu TA, Rhodes PH, Black SB, Shinefield H, Chen RT. Vaccine Safety Datalink T: Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics 2003, 112:1039-1048.
30. Geier DA, Hooker BS, Kern JK, King PG, Sykes LK, Geier MR. A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States. Transl Neurodegeneration 2013, 2:25.